4Duley L, Henderson Smart DJ, Meher S, et aL Antiplatelet agents for preventing preeclampsia and its complications. Cochrane Database Syst Rev, 2007,2 :CD004659.
7Saisto T,Tiitinen A,Ulander VM,et al. Clinical cure of severe, early onset pre-eelampsia withlow molecular weight heparin therapy in primigravida with hyperreaction luteinalis and thrombophitia. Human Reprod,2004,19(3): 725-728.
8Sergio F, Maria Clara D,Gabriella F,et al Prophylaxis of recurrent preeelampsia: low-molecular- weight heparin plus low-dose aspirin versus low dose aspirin alone. Hypertens Pregnancy,2006,25(2) :115-127.
9Urban G, Verqan IP, Tiron IR, et al. Antithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in an antecedent pregnancy. Int J Fertil Womens Med,2007, 52( 2-3): 59-67.
10Ginsberg JS, Bates SM. Management of venous thromboembolism during pregnancy. J Thromb Haemost, 2003,1(70) : 1435-1442.
6Kim JH,Jeong MH,Rhew JY,ei ai.Long-term clinical out-comes of platelet glycoprotein II b/HI a inhibitor combinedwith low molecular weight heparin in patients with acutecoronary syndrome[J].Circ J,2005,69(2): 159-164.
7Carlin AJ, Farquharson RG, Quenby SM,et ai.Prospectiveobservational study of bone mineral density during preg-nancy :low molecular weight heparin versus control[J].HumReprod,2004,19(5):1211-1214.
8Mello G,Parretti E’Fatini C,et aZ.Low-molecular-weightheparin lowers the recurrence rate of preeclampsia and re-stores the physiological vascular changes in angiotensin-converting enzyme DD women[J]Hypertension,2005,45(1):86-91.
9Saisto T’Tiitinen A,Ulander VM,et a^Clinical cure of severe,early onset preeclampsia with low molecular weight hep-arin therapy in primigravida with hyperreaction luteinalisand thrombophilia[J].Hum Reprod,2004,19(3) :725-728.
10Ginsberg JS,Bates SM.Management of venous thromboem-bolism during pregnancy[J]J Thromb Haemost,2003,1(7):1435-1442.
